Description
| Product Name | CAT.No | Size |
| Dengue Fever NS1 Antigen Test Device | DMNS1020 | 20T |
| Dengue Fever NS1 Antigen Test Device | DMNS1040 | 40T |
| Dengue Fever IgG/IgM Antibody Test | DNGMC020 | 20T |
| Dengue Fever IgG/IgM Antibody Test | DNGMC040 | 40T |
Product Description
The Biorex Diagnostics Dengue Fever Rapid Tests are high-performance immunochromatographic assays designed for the qualitative detection of dengue virus NS1 antigen and IgG/IgM antibodies in human whole blood, serum, or plasma. These rapid tests provide fast, accurate, and reliable results, supporting early detection, clinical management, and public health monitoring of dengue infections. By enabling timely identification of both acute and secondary infections, the assays help healthcare providers implement appropriate patient care and contribute to outbreak control efforts.
Key Features
- Rapid Detection – qualitative results available within 10–15 minutes, enabling quick clinical decision-making.
- NS1 Antigen and IgG/IgM Antibody Options – detect acute infection, recent exposure, or past dengue infections.
- High Sensitivity and Specificity – ensures accurate identification of dengue infections across various stages of the disease.
- Instrument-Free Testing – suitable for point-of-care, laboratory, and field use, with minimal equipment requirements.
- Ready-to-Use Format – simple preparation, straightforward interpretation, and reduced handling errors.
Benefits
Routine use of the Dengue Fever Rapid Tests supports early recognition of dengue infections, facilitating prompt clinical intervention, risk assessment, and patient monitoring. The tests’ rapid workflow and reliable performance allow healthcare professionals to quickly differentiate between acute and prior infections, improving treatment decisions and minimizing the risk of complications. Their versatile, instrument-free design makes them suitable for a wide range of settings, including hospitals, clinics, mobile units, and field screening in endemic regions.
By providing consistent, high-quality results, these rapid assays enhance public health surveillance and outbreak management, supporting timely epidemiological interventions. Their ease of use and adaptability also reduce training requirements and operational burden, ensuring efficient testing even in resource-limited environments. With Biorex Diagnostics’ expertise in in vitro diagnostics, the Dengue Fever Rapid Tests offer a dependable solution for early detection, effective patient care, and comprehensive dengue monitoring in both clinical and community health contexts.
Contact Us for more information.